Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

Share Price is delayed by 15 minutes
Get Live Data
68.50    0.00 (0.00%)
Bid:
67.00
Ask:
70.00
Spread: 3.00 (4.478%)
Market Cap: £60.33m
CLX Live PriceLast checked at - London Stock Exchange

Intraday Calnex Solutio. Share Chart

Update on Possible Offer

17 Apr 2007 07:01

Calyx Group PLC17 April 2007 Calyx Group plc ("Calyx" or the "Company") Update on Possible Offer Calyx announced on 13 March 2007 that it had received a preliminary approachfrom Maurice Healy and certain members of the Company's senior management team(the "Potential Offeror") that may or may not lead to an offer for the Company.An independent sub-committee of the Board, consisting of the Company'snon-executive directors Gary Kennedy, Neil Parkinson and Nicholas Koumarianos(the "Committee"), was formed to consider the approach and has retained DavyCorporate Finance to act as financial adviser. The Committee has been advised by the Potential Offeror that certain financialand commercial due diligence on the Company has now been prepared and thatnegotiations with potential providers of equity and debt funding are ongoing. It is the intention of the Committee to ascertain in a timely manner whetherthis or any other expression of interest that may be received can be translatedinto a firm proposal capable of being recommended to shareholders. The Committee will update shareholders in relation to these matters in duecourse. Enquiries: Calyx Group plc +353 1 676 3363Gary Kennedy Davy +353 1 679 6363Ronan GodfreyJohn Frain The Directors of the Company accept responsibility for the information containedin this announcement. To the best of the knowledge and belief of the Directorsof the Company (who have taken all reasonable care to ensure such is the case)the information contained in this announcement is in accordance with the factsand does not omit anything likely to affect the import of such information. Davy Corporate Finance Limited, which is regulated in Ireland by the FinancialRegulator, is acting for the Company and no-one else in relation to the Approachand will not be responsible to anyone other than the Company for providingadvice in relation to the Approach. Any person who is the holder of 1 per cent or more of any class of shares in theCompany may be required to make disclosures pursuant to Rule 8.3 of the IrishTakeover Panel Act 1997, Takeover Rules 2001 to 2005. 17 April 2007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20267:30 amRNSDirector Dealing
29th May 20263:00 pmRNSExercise of Options and Total Voting Rights
26th May 20267:00 amRNSFinal Results
14th May 20267:00 amRNSNotice of Presentations
13th Apr 20267:00 amRNSFY26 Trading Update and Notice of Results
30th Mar 20267:00 amRNSHolding(s) in Company
26th Nov 20257:30 amRNSDirector Dealing
18th Nov 20257:00 amRNSInterim Results
6th Nov 202511:30 amRNS-RCalnex and Viavi Partnership
30th Oct 20257:00 amRNSNotice of Results and Presentations
8th Oct 20252:08 pmRNSExercise of Options and Total Voting Rights
16th Sep 20259:09 amRNSExercise of Options and Total Voting Rights
14th Aug 20254:12 pmRNSResult of AGM
14th Aug 20257:00 amRNSAGM Statement
15th Jul 20257:00 amRNSNotice of AGM and posting of Annual Report
16th Jun 20259:52 amRNSLong-Term Incentive Plan Awards
10th Jun 202511:59 amRNSDirector Dealing
20th May 20257:00 amRNSFinal Results
15th May 20257:00 amRNSNotice of Investor Presentation
8th Apr 20257:00 amRNSFY25 Trading Update and Notice of Results
14th Mar 20257:00 amRNSDirector Dealing
29th Jan 202510:48 amRNSExercise of Options
19th Nov 20247:00 amRNSInterim Results
4th Nov 20247:00 amRNSNotice of Results and Investor Presentation
8th Oct 20247:00 amRNSDirector/PDMR Dealing
2nd Oct 20244:57 pmRNSResult of General Meeting
6th Sep 20247:00 amRNSNotice of General Meeting
22nd Aug 20245:18 pmRNSResult of AGM
22nd Aug 20247:00 amRNSAGM Statement
18th Jul 20249:08 amRNSNotice of AGM
17th Jul 20242:00 pmRNSLong-Term Incentive Plan Awards
21st May 20247:00 amRNSFY24 Final Results
10th Apr 20247:00 amRNSNotice of Investor Presentation
3rd Apr 20247:00 amRNSFY24 Trading Update and Notice of Results
21st Feb 20249:28 amRNSExercise of Options
14th Feb 20241:08 pmRNSExercise of Options
12th Dec 20233:47 pmRNSPDMR Dealings
21st Nov 20237:00 amRNSInterim Results
1st Nov 202312:24 pmRNSChange of Nominated Adviser
26th Oct 20237:00 amRNSNotice of Investor Presentation
10th Oct 20233:17 pmRNSTrading Update and Notice of Results
25th Aug 20234:36 pmRNSPDMR Dealings
16th Aug 20231:22 pmRNSResult of AGM
16th Aug 20237:00 amRNSAGM Statement
11th Aug 20232:00 pmRNSLong-Term Incentive Plan Awards
17th Jul 20237:00 amRNSNotice of AGM
12th Jul 202312:05 pmRNSDirector/PDMR Dealings
12th Jun 20234:34 pmRNSPDMR Dealings
23rd May 20237:00 amRNSFY23 Final Results
11th May 20239:00 amRNSPDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.